These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 22133643

  • 1. Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs.
    Dempfle CE, Hennerici MG.
    Cerebrovasc Dis; 2011; 32(6):616-9. PubMed ID: 22133643
    [No Abstract] [Full Text] [Related]

  • 2. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
    Casado Naranjo I, Portilla-Cuenca JC, Jiménez Caballero PE, Calle Escobar ML, Romero Sevilla RM.
    Cerebrovasc Dis; 2011; 32(6):614-5. PubMed ID: 22133608
    [No Abstract] [Full Text] [Related]

  • 3. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
    Takeuchi S, Wada K, Nagatani K, Otani N, Osada H, Nawashiro H.
    Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979
    [No Abstract] [Full Text] [Related]

  • 4. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
    Pfeilschifter W, Bohmann F, Baumgarten P, Mittelbronn M, Pfeilschifter J, Lindhoff-Last E, Steinmetz H, Foerch C.
    Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
    [Abstract] [Full Text] [Related]

  • 5. Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?
    Pollack CV, Levy JH, Eikelboom J, Weitz JI, Sellke FW, Huisman MV, Steiner T, Kamphuisen P, Bernstein RA.
    Am J Emerg Med; 2014 Nov; 32(11):1433-4. PubMed ID: 25239691
    [No Abstract] [Full Text] [Related]

  • 6. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
    Kono S, Deguchi K, Omote Y, Yunoki T, Yamashita T, Kurata T, Ikeda Y, Abe K.
    J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
    [Abstract] [Full Text] [Related]

  • 7. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
    Diogo C, Duarte J, Sobral S, Pestana P, Nzwalo H, Rita H, Sousa E Costa J.
    Am J Emerg Med; 2014 Nov; 32(11):1435.e1-2. PubMed ID: 24881517
    [Abstract] [Full Text] [Related]

  • 8. Acute adrenal failure following anticoagulation with dabigatran after hip replacement and thrombolysis for massive pulmonary embolism.
    Best M, Palmer K, Jones QC, Wathen CG.
    BMJ Case Rep; 2013 Jan 11; 2013():. PubMed ID: 23314877
    [Abstract] [Full Text] [Related]

  • 9. Dabigatran.
    Murphy L, Lawler L, Kavanagh EC.
    AJNR Am J Neuroradiol; 2011 Jan 11; 32(10):E195. PubMed ID: 22084193
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.
    Rybinnik I, Mullen MT, Messe S, Kasner SE, Cucchiara B.
    J Stroke Cerebrovasc Dis; 2013 Nov 11; 22(8):1312-6. PubMed ID: 23313461
    [Abstract] [Full Text] [Related]

  • 11. Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Edwards DB, Silverberg J.
    Ann Intern Med; 2011 Apr 19; 154(8):570; author reply 570-1. PubMed ID: 21502658
    [No Abstract] [Full Text] [Related]

  • 12. Dabigatran: a primer for neurosurgeons.
    Fugate JE, Rabinstein AA, McBane RD, Lanzino G.
    World Neurosurg; 2013 Jan 19; 79(1):154-8. PubMed ID: 22722043
    [Abstract] [Full Text] [Related]

  • 13. Use of prothrombin complex concentrates for urgent reversal of dabigatran in the Emergency Department.
    Díaz MQ, Borobia AM, Núñez MA, Virto AM, Fabra S, Casado MS, García-Erce JA, Samama CM.
    Haematologica; 2013 Nov 19; 98(11):e143-4. PubMed ID: 24186317
    [No Abstract] [Full Text] [Related]

  • 14. [Pharmacological sheet. Dabigatran, oral administration (Pradaxa)].
    Duh PD, Leuckx PS, Warnez PM.
    J Pharm Belg; 2012 Mar 19; (1):37-8. PubMed ID: 22536682
    [No Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP.
    Ann Intern Med; 2011 Jan 04; 154(1):1-11. PubMed ID: 21041570
    [Abstract] [Full Text] [Related]

  • 16. Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion.
    Simonsen CZ, Steiner T, Tietze A, Damgaard D.
    J Stroke Cerebrovasc Dis; 2014 Feb 04; 23(2):e133-4. PubMed ID: 24103671
    [Abstract] [Full Text] [Related]

  • 17. Ischemic stroke in an obese patient receiving dabigatran.
    Breuer L, Ringwald J, Schwab S, Köhrmann M.
    N Engl J Med; 2013 Jun 20; 368(25):2440-2. PubMed ID: 23782198
    [No Abstract] [Full Text] [Related]

  • 18. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
    Folyovich A, Varga V, Béres-Molnár KA, Vadasdi K, Bereczki D.
    J Stroke Cerebrovasc Dis; 2014 Mar 20; 23(3):580-2. PubMed ID: 23721623
    [Abstract] [Full Text] [Related]

  • 19. Tissue plasminogen activator for ischemic stroke: unintended consequences.
    J Emerg Nurs; 2003 Apr 20; 29(2):96-7. PubMed ID: 12660689
    [No Abstract] [Full Text] [Related]

  • 20. The smoking-thrombolysis paradox and acute ischemic stroke.
    Fisher M.
    Neurology; 2006 Feb 14; 66(3):458; author reply 458. PubMed ID: 16476964
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.